Results 131 to 140 of about 71,564 (304)

Evaluation of the intraventricular hemodynamics of patients with left ventricular dysfunction via vector flow mapping

Frontiers in Cardiovascular Medicine
BackgroundVorticity, measured via new vector flow mapping (VFM), a quantitative marker of vortex dynamics, can reflect hemodynamic changes more sensitively, potentially offering complementary information to conventional echocardiographic indices of ...
Qun Xu, Li Hao, Guang Yang, Mei Zhang, Mingxue Di   +4 more
doaj   +1 more source

Cardiac images show an example of left and right ventricular function data obtained from the patient at end-diastole phase using MRI.

, 2014
Cardiac images show an example of left and right ventricular function data obtained from the patient at end-diastole phase using MRI.
Zhi-gang Yang (534385), Hua-yan Xu (624824), Jia-yu Sun (624822), Ying-kun Guo (624825), Ge Zhang (112487), Ling-yi Wen (624823), Shuai Zhang (115662)   +6 more
core   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu   +16 more
wiley   +1 more source

Simultaneous 3D aortic lumen and vessel wall imaging at 0.55 T at either systole or diastole

PurposeTo evaluate the feasibility of a novel, non-contrast enhanced, 3D, simultaneous bright-blood, and black-blood sequence (iT2prep-BOOST) for aortic imaging at 0.55 T at either systole or diastole.
Prieto Vásquez, Claudia, Prieto, Claudia; id_orcid, Castillo Passi, Carlos, Fotaki, Anastasia, Botnar, René M; id_orcid, Kunze, Karl P., Castillo-Passi, Carlos, Littlewood, Simon; id_orcid, Paredes, Matias, Kunze, Karl P, Paredes Gálvez, Matías Ignacio, Botnar, René Michael, Littlewood, Simon   +12 more
core   +1 more source

Expert Perspectives: Toward Treat‐to‐Target Management in Adult Idiopathic Inflammatory Myopathies

Arthritis &Rheumatology, EarlyView.
Treat‐to‐target has transformed the management of several rheumatic diseases through predefined therapeutic goals, structured disease assessment, and timely treatment adjustment. Despite major advances in the understanding and treatment of idiopathic inflammatory myopathies (IIM), a formal treat‐to‐target framework for adult IIM has not yet been ...
Shiri Keret, Nantakarn Pongtarakulpanit, Rohit Aggarwal   +2 more
wiley   +1 more source

Microscopic CAM artery images and vessel boundaries at systole and diastole (bifurcated arteries).

, 2016
(A) Arterial bifurcation images in CAMs and (B) corresponding vessel boundaries detected at peak systole and late diastole. Artery images were obtained from four ex ovo samples (#1: HH 36; #2: HH 37; #3; HH 36; #4: HH 36).
Kweon-Ho Nam (840875), Chong Hyun Lee (840878), Gicheol Ra (840877), Juho Kim (840876), Dong-Guk Paeng (840879)   +4 more
core   +1 more source

Initial treatment strategies and outcomes across haemodynamic thresholds and risk stratification in incident systemic sclerosis–associated pulmonary arterial hypertension: a EUSTAR analysis

Arthritis &Rheumatology, Accepted Article.
Objective Real‐world initial treatment strategies in SSc‐PAH remain incompletely described. We aimed to characterise these strategies across haemodynamic thresholds and risk strata and evaluate outcome associations. Methods We analysed treatment‐naïve SSc‐PAH patients in EUSTAR (2000–2021) fulfilling the 2022 haemodynamic definition.
Hilde Jenssen Bjørkekjær, Cosimo Bruni, Kaspar Broch, Cathrine Brunborg, Patricia E Carreira, Paolo Airò, Carmen Pilar Simeón‐Aznar, Marie‐Elise Truchetet, Alessandro Giollo, Alexandra Balbir‐Gurman, Mickael Martin, Christopher P Denton, Armando Gabrielli, Francesco Del Galdo, Madelon C. Vonk, Håvard Fretheim, Helle Bitter, Øyvind Midtvedt, Arne K. Andreassen, Sverre Høie, Yoshiya Tanaka, Gabriela Riemekasten, Ulf Müller‐Ladner, Marco Matucci‐Cerinic, Ivan Castellví, Elise Siegert, Eric Hachulla, Øyvind Molberg, Oliver Distler, Anna‐Maria Hoffmann‐Vold, on behalf of the EUSTAR collaborators   +30 more
wiley   +1 more source

MDCT evaluation of dynamic changes in aortic root parameters during the cardiac cycle in patients with aortic regurgitation

Scientific Reports
Objectives: To investigate the dynamic changes in multiple planes and parameters of the aortic root region at different phases of the cardiac cycle in patients with aortic regurgitation (AR) using multi-detector row computed tomography (MDCT). To provide
Shuai Zhang, Ting Huang, Yun Lu, Xi Guo, Quanliang Shang   +4 more
doaj   +1 more source

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

British Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang, Ana Soldo, Olgica Velkovski Škopić, Sunčana Vlah Tomičević, Tin Šaban, Andrej Belančić, Ana Jelaković, Josipa Josipović, Mihaela Marinović Glavić, Ivan Pećin, Luka Prgomet, Tajana Željković Vrkić, Bojan Jelaković   +12 more
wiley   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source